The medical-technology company, Disetronic, said on Tuesday that its first half net profit to the end of September rose to SFr20.9 million ($11.9 million). That's an increase of 15 per cent over the same period last previous year.This content was published on November 21, 2000 - 11:17
The Burgdorf-based enterprise said it expects sales to top the SFr300 million mark for the first time this year. The company makes infusion systems such as insulin pumps.
Sales in the first half were SFr145.1 million, up from SFr118.3 million for the first six months of 1999. Sales grew by more than 25 per cent in the second quarter of the business year alone.
Disetronic said its expectations for strong growth in the second half were based on new systems such as the D-TRON insulin pump which had met with unexpectedly high demand.
swissinfo with agencies
This article was automatically imported from our old content management system. If you see any display errors, please let us know: firstname.lastname@example.org